Who are the SPECT and SPECT-CT Market Top Companies and What are Their Offerings?

What are the Major Recent Developments in the SPECT and SPECT-CT Market?
- In April 2026, a Gamma Camera (SPECT-CT) and a high-dose therapy ward were launched by All India Institute of Medical Sciences (AIIMS), Mangalagiri. The system allows detailed functional imaging of various organs, drives early diagnosis, and supports more than 30 types of scans.
- In January 2026, a successful acquisition of Lantheus' SPECT business was announced by SHINE. The SPECT imaging agents such as Cardiolite®, NEUROLITE®, and Xenon Xe-133 Gas are also included in the product portfolio.
Market Ecosystem Analysis
| Ecosystem Segment | Major Participants | Explanation |
| Technology Providers | Siemens Healthineers, GE HealthCare, Philips, Canon Medical Systems | Develop detector technology, image reconstruction, hybrid imaging platforms, AI-enabled workflow |
| Product Manufacturers | Siemens Healthineers, GE HealthCare, Philips, Spectrum Dynamics Medical, Mediso, DDD-Diagnostic | Manufacture SPECT and SPECT-CT scanners and imaging hardware |
| Service Providers | RadNet, Alliance Medical, I-MED Radiology Network, hospital imaging departments | Provide nuclear medicine diagnostic imaging services |
| Platform Providers | Siemens Healthineers, GE HealthCare, Philips, Canon Medical Systems | Imaging workflow platforms, PACS integration, enterprise imaging solutions |
| CROs/CDMOs (Radiopharmaceutical Research) | Cardinal Health Nuclear & Precision Health Solutions, Curium, Jubilant Radiopharma | Support clinical imaging studies and radiopharmaceutical distribution |
| Software Vendors | Hermes Medical Solutions, Mirada Medical, MIM Software, Siemens Healthineers | Image processing, quantitative analysis, dosimetry, AI-assisted interpretation |
| Research Institutions | Society of Nuclear Medicine and Molecular Imaging (SNMMI), European Association of Nuclear Medicine (EANM), Mayo Clinic, Memorial Sloan Kettering Cancer Center | Advance clinical protocols, imaging research, and nuclear medicine innovation |
| End-User Industries | Hospitals, Cancer Centers, Cardiology Centers, Diagnostic Imaging Networks, Research Hospitals | Utilize SPECT/SPECT-CT systems for routine clinical diagnosis and research |
PECT and SPECT-CT Market Value Chain Analysis
R&D
- The R&D of the SPECT and SPECT-CT focuses on the integration of AI-driven quantification and CZT digital detectors to enable precise dosimetry for theranostics.
- Key players: GE HealthCare, Siemens Healthineers, Spectrum Dynamics Medical.
Clinical Trials and Regulatory Approvals
- The spatial resolution, attenuation correction efficacy, uniformity, diagnostic accuracy, and substantial equivalence to predicate devices are evaluated in the clinical trials and regulatory approvals of the SPECT and SPECT-CT.
- Key players: GE HealthCare, Siemens Healthineers, Philips Healthcare.
Patient Support and Services
- The specialized educational programs, financial assistance, and clinical support teams for patient guidance are provided in the patient support and services of the SPECT and SPECT-CT.
- Key players: GE HealthCare, Siemens Healthineers, Spectrum Dynamics Medical.
| Tier 1 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| GE HealthCare | Chicago, Illinois | USA | Global leader with extensive installed base and comprehensive nuclear imaging portfolio | NM/CT 870 CZT, Discovery NM/CT, Xeleris imaging platform |
| Siemens Healthineers | Erlangen, Bavaria | Germany | Leading supplier of hybrid molecular imaging systems worldwide | Symbia Intevo, Symbia Pro.specta, Symbia Evo |
| Philips | Amsterdam | Netherlands | Major global provider of nuclear medicine imaging solutions | BrightView XCT, BrightView SPECT systems |
| Canon Medical Systems | Otawara, Tochigi | Japan | Established hybrid imaging manufacturer with strong Asia-Pacific presence | Celesteion hybrid imaging integration, nuclear medicine workflow |
| Spectrum Dynamics Medical | Caesarea | Israel | Global leader in dedicated CZT cardiac SPECT technology | D-SPECT, VERITON-CT, VERITON 400 Series |
| Tier 2 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Mediso Ltd. | Budapest | Hungary | Leading European manufacturer specializing in SPECT-CT systems | AnyScan SC, AnyScan TRIO SPECT/CT |
| DDD-Diagnostic A/S | Hørsholm | Denmark | Specialized nuclear medicine equipment manufacturer | CorCam gamma camera, SPECT systems |
| MILabs B.V. | Utrecht | Netherlands | Strong presence in preclinical SPECT/CT imaging | U-SPECT platform, VECTor imaging systems |
| Neusoft Medical Systems | Shenyang, Liaoning | China | Expanding global molecular imaging portfolio | NeuSight SPECT/CT solutions |
| SurgicEye GmbH | Munich, Bavaria | Germany | Specialized intraoperative nuclear imaging and hybrid imaging solutions | declipseSPECT navigation technologies |
| Tier 3 | ||||
| Company Name | Headquarters | Country | Why Relevant to This Market | Key Products/Services Related to Keyword |
| Cubresa Inc. | Winnipeg, Manitoba | Canada | Emerging developer of compact MRI-compatible SPECT technology | NuPET/SPECT preclinical imaging systems |
| Digirad Corporation | Suwanee, Georgia | USA | Specialized provider of portable nuclear imaging systems | Cardius portable SPECT cameras |
| Oncovision | Valencia | Spain | Innovative molecular imaging developer | MAMMI PET and SPECT-related imaging technologies |
| Sedecal Molecular Imaging | Madrid | Spain | Growing manufacturer of preclinical molecular imaging platforms | SuperArgus PET/SPECT/CT systems |
| MiE GmbH | Rostock, Mecklenburg-Vorpommern | Germany | Developer of specialized nuclear medicine software and imaging technologies | SPECT processing software and workflow solutions |
SPECT and SPECT-CT Market Growth
The global SPECT and SPECT-CT market size is calculated at USD 2.78 billion in 2025, driven by growth in chronic disease incidences globally. The market continues to grow USD 2.97 billion in 2026. It is expected to reach USD 5.42 billion by 2035. growing at a CAGR of 6.9% from 2026 to 2035.

Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking